Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Rare blood clots should be listed as possible side-effects of AstraZeneca vaccine: EMA

The European Medicines Agency on Wednesday announced the results of its investigation into the Oxford-AstraZeneca COVID-19 vaccine amid reports of possible blood clots following inoculation, saying that the unusual blood clots should be listed as “possible side-effects” of the vaccine, but refrained from adding any new restrictions to the vaccination including on age.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article